Professor Michael Kassiou, Professor of Medicinal Chemistry and Academic Director of the Drug Discovery Initiative, The University of Sydney.
Michael received his PhD in Organic Chemistry in 1992 from UNSW. He subsequently took up positions at ANSTO, the CEA-Service Hospitalier Frédéric Joliot Life Sciences group in France and the Johns Hopkins Medical Institutes in Baltimore USA. In 1996 he was awarded a Fogerty Fellowship based at the NIH National Institute of Drug Abuse (NIDA) USA. He then moved back to Sydney to Royal Prince Alfred Hospital as a Principal Hospital Scientist. In 2006, he took up a position at the University of Sydney in which he is currently Professor of Medicinal Chemistry and Academic Director of the Drug Discovery Initiative. He is the Editor for the Journal of Labelled Compounds and Radiopharmaceuticals, Chief Editor for Frontiers in Medicinal and Pharmaceutical Chemistry, and Associate Editor for ACS Chemical Neuroscience. He is an editorial advisory board member for ChemMedChem and Trends in Pharmacological Sciences.